Eric H. Bjerkholt
2016 - Sunesis Pharmaceuticals
In 2016, Eric H. Bjerkholt earned a total compensation of $869.7K as Former Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals, which was the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,000 |
|---|---|
| Option Awards | $305,881 |
| Salary | $410,500 |
| Other | $4,306 |
| Total | $869,687 |
Bjerkholt received $410.5K in salary, accounting for 47% of the total pay in 2016.
Bjerkholt also received $149K in non-equity incentive plan, $305.9K in option awards and $4.3K in other compensation.
Rankings
In 2016, Eric H. Bjerkholt's compensation ranked 8,903rd out of 14,075 executives tracked by ExecPay. In other words, Bjerkholt earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,903 out of 14,075 | 37th |
Division Manufacturing | 3,450 out of 5,486 | 37th |
Major group Chemicals And Allied Products | 1,173 out of 1,900 | 38th |
Industry group Drugs | 925 out of 1,543 | 40th |
Industry Pharmaceutical Preparations | 736 out of 1,173 | 37th |
Source: SEC filing on April 25, 2018.
Bjerkholt's colleagues
We found one more compensation record of an executive who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2016.
2016
Daniel Swisher
Sunesis Pharmaceuticals